Novamind Launches Psychedelic Therapy Protocol for Frontline Healthcare Workers
Novamind and the Wholeness Center to launch clinical offering in Utah and ColoradoTORONTO, ON / ACCESSWIRE / June 10, 2021...
Day: June 10, 2021
Axon Neuroscience to Present at 2021 BIO Digital
Axon Neuroscience to present its 2nd generation COVID-19 monoclonal antibody ACmab1 at the premier biotech eventACmab1 has a superior efficacy...
NervGen Pharma Enters into Research Agreement with Sylics to Study NVG-291 in Alzheimer’s Disease Models
NervGen Preparing for Upcoming Phase 1b Clinical Trial in Alzheimer's DiseaseVancouver, British Columbia--(Newsfile Corp. - June 10, 2021) - NervGen...
Awakn Life Sciences to Participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
Toronto, Ontario--(Newsfile Corp. - June 10, 2021) - Awakn Life Sciences Inc. (Awakn), a biotechnology company with clinical operations researching,...
Xenco Medical Unveils HoloMedX, the First Glasses-Free Holographic Surgical Simulation Platform at the VR/AR Global Summit
SAN DIEGO--(BUSINESS WIRE)--On June 4th, 2021, Xenco Medical unveiled HoloMedX, the first glasses-free holographic surgical simulation platform during a presentation...
Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. NDA Phase 3 Clinical Trials for iDose® TR
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Dutch Seeds Shop Boasts Cannabis Cup-Winning Marijuana Seeds, Caters to US$13.5 Billion Sector
Dutch Seeds Shop aims to make its extensive line of products more available in countries that legalize the use of...
Xlife Sciences AG: Breakthrough in Drug Development
First available holistic medical drug to treat Covid-19 and flu viruses ZUERICH, SWITZERLAND / ACCESSWIRE / June 10, 2021 / As a...
Allysta Pharmaceuticals, Inc. Announces Start of Phase 1 Clinical Trial of ALY688-SR, a Novel First-in-Class Peptide that Targets Adiponectin Signaling
Phase 1 Study InitiatedAddition of Timothy Sullivan to Board of DirectorsBELLEVUE, WA / ACCESSWIRE / June 10, 2021 / Allysta...